✦ LIBER ✦

Diabetic control on once- and twice-daily insulin injections

✍ Scribed by B. J. Boucher

Publisher: Springer
Year: 1980
Tongue: English
Weight: 94 KB
Volume: 19
Category: Article
ISSN: 0012-186X
DOI: 10.1007/bf00281832

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diabetic control in patients treated wit

Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins

✍ R. S. Gray; D. Q. Borsey; D. M. Fraser; A. B. Kurtz; S. Rainbow; A. F. Smith; L. 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 524 KB

Differences in metabolic effects of twic

Differences in metabolic effects of twice daily versus multiple daily insulin injections in children with type 1 diabetes

✍ N Abid; L Porter; E Day; N Krone; W Högler; J Kirk; N Shaw; T Barrett 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 191 KB

## Abstract We aimed to compare children started on twice daily injections (BD) versus multiple daily injections (MDI) from diagnosis, using HbA~1c~ and weight gain as outcome measures. In our unit, newly diagnosed children were started on BD insulin until 2005 when we changed to MDI. Those on BD

Insulin injection technique and diabetic

Insulin injection technique and diabetic control

✍ Burden, A C ;Jones, G R ;Blandford, R L 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

The antianginal efficacy and tolerabilit

The antianginal efficacy and tolerability of controlled-release metoprolol once daily: A comparison with conventional metoprolol tablets twice daily

✍ K. Egstrup; T. Gundersen; R. Härkönen; E. Karlsson; B. Lundgren 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 657 KB

Metaplan group education for IDDM patien

Metaplan group education for IDDM patients on multiple (≥4) daily insulin injections improves self-efficacy and metabolic control

✍ D.M. van Doorn-Scheele; L.G. van Doorn 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Comparison of the efficacy, tolerability

Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma

✍ S. D. Gunn; J. G. Ayres; R. M. A. Follows; S. M. McConchie 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 549 KB

The aim of the study was to compare the efficacy, tolerability and patient acceptability of bambuterol (Bambec ®) against controlled release (CR) salbutamol (Volmax ®) in the treatment of nocturnal asthma. One hundred and fifty two asthmatic patients aged 17-78 years, using \_> 800 ~tg/day of an in